Clinical Trials Logo

Anticoagulation Reversal clinical trials

View clinical trials related to Anticoagulation Reversal.

Filter by:
  • None
  • Page 1

NCT ID: NCT03473132 Recruiting - Anticoagulation Clinical Trials

Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC)

KVAD
Start date: March 15, 2018
Phase: Phase 4
Study type: Interventional

Prospective assessment of vitamin K dependent coagulation factor levels after temporary warfarin reversal in participants with left ventricular assist devices (LAVD).

NCT ID: NCT02207257 Completed - Clinical trials for Anticoagulation Reversal

Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With Edoxaban

Start date: March 2014
Phase: Phase 2
Study type: Interventional

This study will evaluate the establishment of anticoagulation ("re-anticoagulation") of subjects with edoxaban following reversal by PER977 and will identify a dose regimen of PER977 that reverses the effects of edoxaban for up to 21 hours.